$29.46
0[0.00%]
At close: Apr 18
$29.46
0[0.00%]
PreMarket: 4:00PM EDT
OrthoPediatrics
(NASDAQ:KIDS)OrthoPediatrics Stock (NASDAQ:KIDS), Analyst Ratings, Price Targets, Predictions
OrthoPediatrics Corp has a consensus price target of $47.44, established from looking at the 34 latest analyst ratings. The last 3 analyst ratings were released from Needham, Truist Securities, and Stifel on April 10, 2024, March 8, 2024, and March 7, 2024. With an average price target of $34.33 between Needham, Truist Securities, and Stifel, there's an implied 16.54% upside for OrthoPediatrics Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Needham
Truist Securities
Stifel
JMP Securities
Truist Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for OrthoPediatrics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/10/2024 | KIDS | Buy Now | OrthoPediatrics | $29.46 | 25.59% | Needham | Mike Matson | → $37 | Reiterates | Buy → Buy | Get Alert |
| 03/08/2024 | KIDS | Buy Now | OrthoPediatrics | $29.46 | 8.62% | Truist Securities | Samuel Brodovsky | $31 → $32 | Maintains | Hold | Get Alert |
| 03/07/2024 | KIDS | Buy Now | OrthoPediatrics | $29.46 | 15.41% | Stifel | Rick Wise | $32 → $34 | Maintains | Buy | Get Alert |
| 03/07/2024 | KIDS | Buy Now | OrthoPediatrics | $29.46 | 25.59% | Needham | Mike Matson | → $37 | Reiterates | Buy → Buy | Get Alert |
| 03/07/2024 | KIDS | Buy Now | OrthoPediatrics | $29.46 | 69.72% | JMP Securities | David Turkaly | → $50 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/25/2024 | KIDS | Buy Now | OrthoPediatrics | $29.46 | 5.23% | Truist Securities | Kaila Krum | $39 → $31 | Downgrade | Buy → Hold | Get Alert |
| 12/22/2023 | KIDS | Buy Now | OrthoPediatrics | $29.46 | 32.38% | Truist Securities | Richard Newitter | $35 → $39 | Maintains | Buy | Get Alert |
| 12/07/2023 | KIDS | Buy Now | OrthoPediatrics | $29.46 | 69.72% | JMP Securities | David Turkaly | $60 → $50 | Maintains | Market Outperform | Get Alert |
| 11/08/2023 | KIDS | Buy Now | OrthoPediatrics | $29.46 | 18.81% | Truist Securities | Richard Newitter | $31 → $35 | Maintains | Buy | Get Alert |
| 11/07/2023 | KIDS | Buy Now | OrthoPediatrics | $29.46 | 25.59% | Needham | Mike Matson | $55 → $37 | Maintains | Buy | Get Alert |
| 10/04/2023 | KIDS | Buy Now | OrthoPediatrics | $29.46 | 76.51% | BTIG | Ryan Zimmerman | $59 → $52 | Maintains | Buy | Get Alert |
| 09/01/2023 | KIDS | Buy Now | OrthoPediatrics | $29.46 | 103.67% | JMP Securities | David Turkaly | → $60 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/02/2023 | KIDS | Buy Now | OrthoPediatrics | $29.46 | 73.12% | Truist Securities | Richard Newitter | $57 → $51 | Maintains | Buy | Get Alert |
| 08/01/2023 | KIDS | Buy Now | OrthoPediatrics | $29.46 | 103.67% | JMP Securities | David Turkaly | → $60 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/01/2023 | KIDS | Buy Now | OrthoPediatrics | $29.46 | 86.69% | Needham | Mike Matson | → $55 | Reiterates | Buy → Buy | Get Alert |
| 05/02/2023 | KIDS | Buy Now | OrthoPediatrics | $29.46 | 86.69% | Needham | Mike Matson | $51 → $55 | Maintains | Buy | Get Alert |
| 05/02/2023 | KIDS | Buy Now | OrthoPediatrics | $29.46 | 103.67% | JMP Securities | David Turkaly | → $60 | Reiterates | → Market Outperform | Get Alert |
| 04/17/2023 | KIDS | Buy Now | OrthoPediatrics | $29.46 | 73.12% | Needham | Mike Matson | → $51 | Maintains | Buy | Get Alert |
| 04/17/2023 | KIDS | Buy Now | OrthoPediatrics | $29.46 | 93.48% | Truist Securities | Richard Newitter | $53 → $57 | Maintains | Buy | Get Alert |
FAQ
What is the target price for OrthoPediatrics (KIDS)?
The latest price target for OrthoPediatrics (NASDAQ: KIDS) was reported by Needham on April 10, 2024. The analyst firm set a price target for $37.00 expecting KIDS to rise to within 12 months (a possible 25.59% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for OrthoPediatrics (KIDS)?
The latest analyst rating for OrthoPediatrics (NASDAQ: KIDS) was provided by Needham, and OrthoPediatrics reiterated their buy rating.
When was the last upgrade for OrthoPediatrics (KIDS)?
There is no last upgrade for OrthoPediatrics.
When was the last downgrade for OrthoPediatrics (KIDS)?
The last downgrade for OrthoPediatrics Corp happened on January 25, 2024 when Truist Securities changed their price target from $39 to $31 for OrthoPediatrics Corp.
When is the next analyst rating going to be posted or updated for OrthoPediatrics (KIDS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OrthoPediatrics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OrthoPediatrics was filed on April 10, 2024 so you should expect the next rating to be made available sometime around April 10, 2025.
Is the Analyst Rating OrthoPediatrics (KIDS) correct?
While ratings are subjective and will change, the latest OrthoPediatrics (KIDS) rating was a reiterated with a price target of $0.00 to $37.00. The current price OrthoPediatrics (KIDS) is trading at is $29.46, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.